Predictive Power: Analyzing the Evolution of Models in Preclinical CRO Market Technology Adoption
The intensity of Preclinical CRO Market Technology Adoption is dictated by the industry’s central challenge: reducing the high clinical attrition rate caused by poor predictive power in early-stage studies. Traditional reliance on simple in vivo (animal) models, while regulatory standard, often fails to accurately translate to human outcomes. Consequently, a massive trend in technology...
0 Comentários 0 Compartilhamentos 11 Visualizações 0 Anterior